Pages that link to "Q40502210"
Jump to navigation
Jump to search
The following pages link to IkappaBalphaM suppresses angiogenesis and tumorigenesis promoted by a constitutively active mutant EGFR in human glioma cells (Q40502210):
Displaying 14 items.
- The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered (Q27015045) (← links)
- Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma (Q28087306) (← links)
- Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma (Q28473229) (← links)
- Malignant Gliomas: Diagnosis and Treatment (Q34061176) (← links)
- Targeting angiogenesis with integrative cancer therapies (Q34495463) (← links)
- Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2. (Q35840361) (← links)
- Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization (Q35893456) (← links)
- Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells (Q36214610) (← links)
- Mechanisms of angiogenesis in gliomas (Q36429021) (← links)
- Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma (Q36808787) (← links)
- NF-kappaB and STAT3 signaling in glioma: targets for future therapies (Q37457873) (← links)
- Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates (Q38722183) (← links)
- CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. (Q40724369) (← links)
- Antiphospholipid antibodies affect human endometrial angiogenesis. (Q44526752) (← links)